2018
DOI: 10.1016/j.addbeh.2018.05.017
|View full text |Cite
|
Sign up to set email alerts
|

Future directions for medication assisted treatment for opioid use disorder with American Indian/Alaska Natives

Abstract: The U.S. is experiencing an alarming opioid epidemic, and although American Indians and Alaska Natives (AI/AN) are especially hard hit, there is a paucity of opioid-related treatment research with these communities. AI/ANs are second only to Whites in the U.S. for overdose mortality. Thus, the National Institute on Drug Abuse convened a meeting of key stakeholders to elicit feedback on the acceptability and uptake of medication assisted treatment (MAT) for opioid use disorders (OUDs) among AI/ANs. Five themes … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
48
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
7
1

Relationship

3
5

Authors

Journals

citations
Cited by 71 publications
(55 citation statements)
references
References 50 publications
1
48
0
Order By: Relevance
“…Further, some minoritized racial/ethnic group members may be less willing to participate in medication trials because there is a mismatch between cultural views regarding healing and medication treatments in general. For instance, American Indian individuals tend to report a desire for complete healing, which they define as including abstinence from all drugs and pharmaceutical medications (Venner et al, 2018). American Indian communities also tend to perceive randomized trials as unacceptable or unfair, as the control group individuals or communities are seen as receiving lesser care (Dickerson et al, 2020).…”
Section: Discussionmentioning
confidence: 99%
“…Further, some minoritized racial/ethnic group members may be less willing to participate in medication trials because there is a mismatch between cultural views regarding healing and medication treatments in general. For instance, American Indian individuals tend to report a desire for complete healing, which they define as including abstinence from all drugs and pharmaceutical medications (Venner et al, 2018). American Indian communities also tend to perceive randomized trials as unacceptable or unfair, as the control group individuals or communities are seen as receiving lesser care (Dickerson et al, 2020).…”
Section: Discussionmentioning
confidence: 99%
“…A prime example of this is the work by Venner et al at the University of New Mexico. Applying a culturally appropriate lens to evidence‐based interventions such as Motivational Interviewing, this group has improved accessibility and acceptability of medication for addiction treatment (MAT) for addressing the disproportionate impact of substance use related health disparities in American Indian/Alaska Natives 9,10 . Further, within the ongoing opioid crisis, there continues to be decreased initiation and engagement of Black, Latinx, and Native American populations in medication treatment for opioid use disorder (MOUD), while all of these groups have increasing rates of opioid overdose deaths 11 .…”
Section: Dei and Health Outcomes: Deconstructing Gaps In Addiction Trmentioning
confidence: 99%
“…Furthermore, limited treatment access, availability, and utilization among many Indigenous communities exacerbate SU problems (Gone & Calf Looking, ). Sociocultural vulnerabilities and limited treatment infrastructure have been a clear challenge for many Indigenous Nations in light of the recent opioid addiction epidemic, which has had a disproportionately negative impact on many Indigenous communities (Mack, Jones, & Ballesteros, ; Venner et al., ).…”
Section: Introductionmentioning
confidence: 99%